SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-180497
Filing Date
2012-04-25
Accepted
2012-04-25 08:30:38
Documents
7
Period of Report
2012-06-07
Effectiveness Date
2012-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d328966ddef14a.htm DEF 14A 866133
2 GRAPHIC g328966g07o10.jpg GRAPHIC 9013
3 GRAPHIC g328966pc_pg001a.jpg GRAPHIC 1418
4 GRAPHIC g328966pc_pg1b.jpg GRAPHIC 76250
5 GRAPHIC g328966pc_pg1c.jpg GRAPHIC 46149
6 GRAPHIC g328966sig_001.jpg GRAPHIC 5970
7 GRAPHIC g328966sig_002.jpg GRAPHIC 8520
  Complete submission text file 0001193125-12-180497.txt   1071132
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-49839 | Film No.: 12777920
SIC: 2834 Pharmaceutical Preparations